Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates

TheFly reported on February 14 that LifeSci Capital was bullish on CMPS, as the firm initiated coverage on the stock with a ...

Bullish Analyst Opinion on Dyne (DYNE) Follows Rare Disease Drug Progress in Japan

Dyne Therapeutics Inc. (NASDAQ: DYN) is one of the 13 hot stocks to buy with the highest upside potential. As of February 13, ...

Analyst Bullish on Beam Therapeutics (BEAM) Over Drug Program Trajectory

Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the 13 hot stocks to buy with the highest upside potential. On February 9, ...

Novig Raises $75M Series B to Build a Trader-First Sports Prediction Market

Novig, the fastest growing sports trading platform in America, today announced the close of a $75 million Series B round led ...

11 Best Natural and Organic Food Stocks to Buy Now

He was of the view that we are now in a different market, one that does not have the same “love affair” with AI as we had ...

Jefferies Assigns 65–75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.’s (DFTX) DT120 in Phase III

TheFly reported on January 30 that Jefferies initiated coverage of DFTX with a Buy rating and a $30 price target.

Jeffries Highlight Cybin D/B/A Helus Pharma (HELP)’s Science-Driven Psilocybin Therapies as Key Growth Drivers

TheFly reported on February 2 that Jefferies initiated coverage of HELP with a Buy rating and a $22 price target and also highlighted significant upside potential.

Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and Ingrezza

TheFly reported on February 12 that Needham lowered its price target on NBIX to $185 from $187 and maintained a Buy rating. The company is still hopeful about Crenessity ...

Evercore Notes AbbVie Inc.’s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited

TheFly reported on February 4 that Evercore ISI lowered its price target on ABBV to $228 from $232 and maintained an Outperform rating.